Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus

Mario Gaudino1, Antonino Di Franco1, Davide Cao2

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York, USA.

Insights

Women experience worse outcomes for coronary artery disease (CAD) due to biological and sociocultural factors. This review highlights sex-specific differences in CAD treatment outcomes, emphasizing the need for tailored strategies.

Area of Science:

  • Cardiology
  • Sex-based differences in medicine
  • Clinical outcomes research

Background:

  • Coronary artery disease (CAD) affects men and women differently, with women often experiencing poorer outcomes.
  • Biological and sociocultural factors contribute to these sex-based disparities in CAD epidemiology and treatment.
  • Existing clinical studies inadequately represent women, hindering the development of sex-specific management guidelines.

Purpose of the Study:

  • To review current evidence on sex-related differences in coronary artery disease (CAD).
  • To focus on differential outcomes following medical therapy, percutaneous coronary interventions, and coronary artery bypass surgery in men versus women.

Main Methods:

  • Systematic review of existing literature on sex differences in CAD.
  • Analysis of outcomes data from medical therapy, percutaneous coronary interventions, and coronary artery bypass surgery.

Main Results:

  • Women exhibit higher residual platelet reactivity on antiplatelet drugs compared to men.
  • Women face increased adverse cardiovascular outcomes after percutaneous coronary revascularization.
  • Women report higher operative and long-term mortality rates following coronary artery bypass surgery.

Conclusions:

  • Significant sex-based differences exist in CAD outcomes across various treatment modalities.
  • Underrepresentation of women in clinical trials limits understanding and addressing these disparities.
  • Development and implementation of sex-specific management strategies for CAD are crucial.

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...